In the UKPDS (United Kingdom Prospective Diabetes Study), the administration of metformin to overweight patients with type 2 DM reduced the risk of stroke compared to treatment with sulphonylureas or insulin (p = 0.032) [47]. This evidence concerns the gene INS and stroke disorder.